Diabetes (Insulin/Anti-diabetics) Flashcards
Rapid-Acting insulin
Lispro (humalog)
Aspart (novolog)
Inhaled insulin (afreeza)
Onset: 15-30min
Peak: 1-3hrs
Duration: 3-5hrs
Admin within 15min before a meal or immediately after
Short acting
Humulin R
Novolin R
Onset: 30min
Peak: 3hrs
Durations: 8hrs
Administer 30min before a meal
ONLY insulin given IV
Intermediate-Acting Insulin
Humulin N
Novolin N
Onset: 1-2 hrs
Peak effect: 6hrs
Range: 8-13hrs
Duration: up to 24 hrs
Admin once or twice daily
Only subQ
Do not mix w/ other insulin
Also NPH, regular before NPH (clear before cloudy)
Long-Acting Insulin
glargine (lantus)
Detemir (levemir)
Onset:3-4 hrs
Peak: none
Duration: >24hrs
Admin once daily (or split and twice)
Only SubQ
Do not mix with other insulin
Combination: Intermediate Acting/Rapid Acting
Humalog Mix 50/50
Humalog Mix 75/25
Novolog 70/30
Onset: 15-30min
Peak: 1-5hrs
Duration: 11-22hrs
Admin twice daily
15 min before a meal or immediately after
Only subQ
Combination: Intermediate Acting/Short-Acting
Humulin 70/30
Novolin 70/30
Onset:30-90min
Peak: 1.5-6.5hrs
Duration: 18-24hrs
Admin twice daily
30-34 min before a meal
SubQ
Sulfonylureas
Glipizide
Time with meals
Peak: 1-3hrs
MOA: stimulation of insulin secretion from beta cells
Biguanide
Metformin
Contraindicated in renal and hepatic disease
Should be temp. discontinued in pts undergoing radiologic studies with contrast
MOA: decreases hepatic glucose production
decreases intestinal absorption of glucose
improves insulin sensitivity
DPPV-IV inhibitor
Sitagliptin
Can be given with or without food
MOA: inhibitor of dipeptidyl peptidase-4 enzyme that slows the inactivation of incretin hormones involved in regulation of glucose homeostasis.
SGLT-2 inhibitors
Canaglifozin (Inovkana)
Empaglifozin (Jardiance)
Peak: 1-2hrs
Give before meal
MOA: inhibits renal reabsorption of glucose and lowers renal threshold for glucose, resulting increased urinary excretion of glucose
SGLT-2 inhibitors
Canaglifozin (Inovkana)
Empaglifozin (Jardiance)
Peak: 1-2hrs
Give before meal
MOA: inhibits renal reabsorption of glucose and lowers renal threshold for glucose, resulting increased urinary excretion of glucose